Medical News

RSS

Oncopeptides confirms blood-brain-barrier penetration based on data from first patients in glioblastoma Window-of-Opportunity (WoO) study

Oncopeptides AB (publ), a biotech company specializing in difficult-to-treat cancers, today announces data from the first patients in its ongoing clinical Window-of-Opportunity (WoO) study, OP-701 (INSULA), evaluating its proprietary Peptide Drug Conjugate (PDC) platform in glioblastoma.

9 Oct 2026

New research unveils role of innate immune system in pancreatic cancer

Researchers from Adelaide University have demonstrated that blocking a specific immune system gene can reduce pancreatic cancer tumor formation.

9 Oct 2026

Body fat distribution may influence hunger hormones more than daily diet

Body fat distribution may reveal more about hunger hormones than recent diet.

9 Oct 2026

Gut bacteria may help explain why endometriosis pain varies

A study of 50 women with surgically confirmed endometriosis found that differences in gut bacterial composition were associated with menstrual pain, urinary symptoms, and infertility.

9 Oct 2026

Infections caused 1 in 8 cancer cases worldwide in 2024, study finds

Infections drove 1 in 8 cancer cases worldwide in 2024, study finds.

9 Oct 2026

US counties with more medical debt see higher rates of several late-stage cancers

Higher medical debt is linked to more late-stage cancer diagnoses across U.S. counties.

9 Oct 2026

New iron deficiency guidelines raise key blood test cutoffs

ASH 2026 guidelines redefine iron deficiency diagnosis with higher ferritin thresholds, aiming for better detection and management across diverse populations.

9 Oct 2026

What young cancer survivors revealed about stress, exercise and friendship

Adolescent and young adult cancer survivors use exercise and social support to cope with stress, revealing insights for effective mental health interventions.

9 Oct 2026

Feeling mentally exhausted and feeling sleepy aren't the same

Research reveals how task difficulty and sleep restriction uniquely impact cognitive states like drowsiness and fatigue, crucial for safety in high-stakes jobs.

9 Oct 2026

Nearly one-third of new nurse practitioners trained at for-profit schools

For-profit schools appear to be playing an outsized role in training the nation's expanding nurse practitioner workforce, according to a study that found nearly one-third of newly licensed nurse practitioners in four states were educated at for-profit programs in 2024, up from just 2.4% in 2010.

9 Oct 2026

$13.1 million grant backs bacterial therapies for resistant breast cancer

A scientist at Weill Cornell Medicine is working with colleagues at the University of Massachusetts Amherst on new, complementary research efforts engineering therapeutic Salmonella to target critical gaps in treatment for drug-resistant triple-negative breast cancers.

9 Oct 2026

Positive parenting in early childhood linked to stronger brain reward responses

More than one in five adults in the US experience mental illness each year, according to data from the National Alliance on Mental Illness.

9 Oct 2026

SPRED2 coordinates three signaling pathways to suppress liver cancer stemness

Liver cancer is the fifth most commonly diagnosed cancer and the second leading cause of cancer death worldwide. Hepatocellular carcinoma (HCC) accounts for 70-85% of primary liver cancers, and its five-year recurrence rate can reach 70-80%.

8 Oct 2026

Certain gut bacteria may intensify inflammatory responses to vaccines

A person's microbiome may help determine whether they develop a fever after receiving a vaccination, according to a new study.

8 Oct 2026

DNA Typewriter tracks cell divisions and developmental decisions in mice

Scientists have succeeded in reconstructing the family tree of cells in a developing mouse embryo. They recorded cells' relationships, starting when the fertilized egg first split in two and ending after the body with organs took shape.

8 Oct 2026

Rare dendritic cells may promote immune tolerance in metastatic cancer

This study was co-led by Steven Blum, MD. Gary Reynolds, MD, PhD, Samuel Klempner, MD, and Alexandra-Chloé Villani, PhD, jointly supervised the work at the Krantz Family Center for Cancer Research within the Mass General Brigham Cancer Institute and the Mass General Brigham Center for Immunology & Inflammatory Diseases (CIID).

8 Oct 2026

Precise phenotyping improves genetic prediction of sensorineural hearing loss

A team of hearing specialists at Vanderbilt Health analyzed thousands of data samples in the institution’s BioVU biobank to understand genetic susceptibility of sensorineural hearing loss, which is caused by damage to the inner ear.

8 Oct 2026

Nicotinamide riboside fails to slow progression of early Parkinson’s disease

A major clinical trial involving 410 people with early Parkinson's disease has found no clinical benefit from nicotinamide riboside (NR), a compound that increases cellular levels of nicotinamide adenine dinucleotide (NAD). The findings are published in JAMA.

8 Oct 2026

Food insecurity disproportionately affects LGBTQ+ adults in Massachusetts

More than half of LGBTQ+ adults in Massachusetts experienced food insecurity in 2024, according to a new study published in JAMA Network Open.

8 Oct 2026

New long-acting HIV treatment offers hope for drug-resistant infections

A new long-acting HIV treatment could expand options for people who have trouble taking daily pills and whose virus is resistant to some commonly used HIV drugs, according to a new UC San Francisco study.

8 Oct 2026